Garofalo Health Care Stock Current Valuation

GHC Stock  EUR 4.87  0.02  0.41%   
Valuation analysis of Garofalo Health Care helps investors to measure Garofalo Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
4.87
Please note that Garofalo Health's price fluctuation is somewhat reliable at this time. Calculation of the real value of Garofalo Health Care is based on 3 months time horizon. Increasing Garofalo Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Garofalo stock is determined by what a typical buyer is willing to pay for full or partial control of Garofalo Health Care. Since Garofalo Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Garofalo Stock. However, Garofalo Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  4.87 Real  4.82 Hype  4.87 Naive  4.7
The real value of Garofalo Stock, also known as its intrinsic value, is the underlying worth of Garofalo Health Care Company, which is reflected in its stock price. It is based on Garofalo Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Garofalo Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
4.82
Real Value
6.19
Upside
Estimating the potential upside or downside of Garofalo Health Care helps investors to forecast how Garofalo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Garofalo Health more accurately as focusing exclusively on Garofalo Health's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
4.855.325.80
Details
Hype
Prediction
LowEstimatedHigh
3.504.876.24
Details
Naive
Forecast
LowNext ValueHigh
3.334.706.07
Details

Garofalo Health Care Company Current Valuation Analysis

Garofalo Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Garofalo Health Current Valuation

    
  467.88 M  
Most of Garofalo Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Garofalo Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Garofalo Health Care has a Current Valuation of 467.88 M. This is 96.74% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current valuation for all Germany stocks is 97.19% higher than that of the company.

Garofalo Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Garofalo Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Garofalo Health could also be used in its relative valuation, which is a method of valuing Garofalo Health by comparing valuation metrics of similar companies.
Garofalo Health is currently under evaluation in current valuation category among its peers.

Garofalo Fundamentals

About Garofalo Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Garofalo Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Garofalo Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Garofalo Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Garofalo Stock

Garofalo Health financial ratios help investors to determine whether Garofalo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Garofalo with respect to the benefits of owning Garofalo Health security.